Neal Shore, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Invitae
    Date added:
    Date updated:
    04/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    GConcology
    Date added:
    Date updated:
    04/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Foundation Medicine
    Date added:
    Date updated:
    04/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    FerGene
    Date added:
    Date updated:
    04/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Exact Imaging
    Date added:
    Date updated:
    04/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Clovis Oncology
    Date added:
    Date updated:
    04/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Boston Scientific
    Date added:
    Date updated:
    04/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Bristol Myers Squibb
    Date added:
    Date updated:
    04/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Amgen
    Date added:
    Date updated:
    04/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Abbvie
    Date added:
    Date updated:
    04/10/2024

Pages

Return to Operationalizing Checkpoint Inhibitors in Urologic Practice Webcast (2022)